Uses:
- Advanced and metastatic breast cancer.
- Metastatic gastric cancer with increased levels of HER2 proteins.
Therapeutic Effects:
- Biceltis 440mg Injection contains Trastuzumab, which selectively binds to HER2 proteins.
- This stops the growth of cancer cells in HER2 positive breast cancer patients.
Interaction with other drugs:
- Inform your doctor about all medications, including supplements and herbal products, you are taking.
- Certain medications may interact with Biceltis 440mg Injection and cause undesirable side effects.
Safety Advices:
- Pregnancy: Discuss with your physician before taking this medicine if you are pregnant or think you might be pregnant.
- Breastfeeding: Avoid breastfeeding while on treatment with Biceltis 440mg Injection and for at least seven months after the final dose.
- Lungs: Talk to your doctor if you have any lung conditions before starting treatment.
- Liver: Inform your physician if you have any liver disorders before starting Biceltis 440mg Injection.
- Alcohol: Consult your doctor to know if it is safe to consume alcohol while on treatment.
- Driving: Biceltis 440mg Injection can cause unusual tiredness and dizziness, so avoid driving or handling machinery during treatment.
Side Effects:
- Serious: Heart problems, allergic reactions, kidney problems, breathing difficulties.
- Common: Fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.
Word of Advice:
- Inform your doctor if you have a history of allergic reactions to Biceltis 440mg Injection.
- If you have a history of lung disorder or breathing problems, inform your doctor beforehand.
- Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose.
- Monitor your heart parameters regularly during treatment.
FAQs:
Q 1. Is Biceltis 440mg Injection used as a monotherapy in treating breast cancer? Biceltis 440mg Injection is generally given along with chemotherapy medication such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.
Q 2. Does Biceltis 440mg Injection cause heart problems? Yes, Biceltis 440mg Injection can damage the heart muscles. Hence, it is advised to do heart check up every 3 months and continue till 2-5 years after the treatment completion.
Q 3. Can I breastfeed while on treatment with Biceltis 440mg Injection? No, since Trastuzumab tends to pass into breast milk, it is unsafe to breastfeed. Hence, it is advised not to breastfeed for a minimum of 7 months after the treatment with Biceltis 440mg Injection.
Q 4. Can Biceltis 440mg Injection be consumed during pregnancy? No, it is unsafe to consume Biceltis 440mg Injection while you are pregnant. This medicine can cause harm to the baby by reducing the amount of amniotic fluid, the fluid surrounding the womb. It can also cause organ developmental issues such as poor lung development when consumed during pregnancy. If you are planning for pregnancy, it is advised to discuss the birth control methods as this medicine may impair your fertility.
Fact Box:
- Molecule name: Trastuzumab.
- Therapeutic class: Anti-cancer.
- Pharmacological class: HER2 inhibitor.
- Indications:
- Advanced and metastatic breast cancer.
- Metastatic gastric cancer.